V. Wee Yong

V. Wee Yong

Department of Clinical Neurosciences, Hotchkiss Brain Institute at University of Calgary

Affiliated withHotchkiss Brain Institute at University of CalgaryUniversity of Calgary

Research Area

Biography

V. Wee Yong has not added Biography.
If you are V. Wee Yong and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2
Year
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Publication title

Cited by 78

2015
2024

Other Publications

Article
Year
A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis.

Carcinogenesis| PubMed ID: 22159219

2012
2012
2012
2012
2012
Immune cell infiltrates in atypical teratoid/rhabdoid tumors.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques| PubMed ID: 22931701

2012
Prolactin in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 22933621

2013
2013
2012
Remyelination therapy for multiple sclerosis.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics| PubMed ID: 23070731

2013
2012
2013
Environmental factors and their regulation of immunity in multiple sclerosis.

Journal of the neurological sciences| PubMed ID: 23154080

2013
Reply: To PMID 23034914.

Annals of neurology| PubMed ID: 23424070

2013
2013
2013
2013
2013
2013
2013
2013
2013
2013
Screening for inhibitors of microglia to reduce neuroinflammation.

CNS & neurological disorders drug targets| PubMed ID: 24047520

2013
2014
2013
2014
Using magnetic resonance imaging in animal models to guide drug development in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 24263386

2014
2014
2014
Remyelination after spinal cord injury: is it a target for repair?

Progress in neurobiology| PubMed ID: 24582777

2014
2014
Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome.

Journal of neurology, neurosurgery, and psychiatry| PubMed ID: 24935984

2015
2014
Iron in multiple sclerosis: roles in neurodegeneration and repair.

Nature reviews. Neurology| PubMed ID: 25002107

2014
Interactions between microglia and T cells in multiple sclerosis pathobiology.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research| PubMed ID: 25084178

2014
2013
2014
2014
2014
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.

Annals of clinical and translational neurology| PubMed ID: 25356411

2014
Stimulation of monocytes, macrophages, and microglia by amphotericin B and macrophage colony-stimulating factor promotes remyelination.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 25609628

2015
EMMPRIN, an upstream regulator of MMPs, in CNS biology.

Matrix biology : journal of the International Society for Matrix Biology| PubMed ID: 25644103

2015
2015
The promise of futility trials in neurological diseases.

Nature reviews. Neurology| PubMed ID: 25776824

2015
Inefficient clearance of myelin debris by microglia impairs remyelinating processes.

The Journal of experimental medicine| PubMed ID: 25779633

2015
Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 10493747

1999
2000
Metalloproteinases in biology and pathology of the nervous system.

Nature reviews. Neuroscience| PubMed ID: 11433375

2001
P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 11549724

2001
The expression of matrix metalloproteinase-12 by oligodendrocytes regulates their maturation and morphological differentiation.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 15342725

2004
Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 16495447

2006
White matter plasticity and enhanced remyelination in the maternal CNS.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 17314279

2007
Targeting MMPs in acute and chronic neurological conditions.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics| PubMed ID: 17920539

2007
Depletion of Ly6G/Gr-1 leukocytes after spinal cord injury in mice alters wound healing and worsens neurological outcome.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 19158301

2009
2009
2009
Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 19815532

2009
2009
2010
2010
2010
2010
2010
2010
2010
The many faces of EMMPRIN - roles in neuroinflammation.

Biochimica et biophysica acta| PubMed ID: 20674741

2011
EMMPRIN: a novel regulator of leukocyte transmigration into the CNS in multiple sclerosis and experimental autoimmune encephalomyelitis.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 21228176

2011
Analysis of the mitochondrial proteome in multiple sclerosis cortex.

Biochimica et biophysica acta| PubMed ID: 21295140

2011
2011
The good, the bad and the ugly. Macrophages/microglia with a focus on myelin repair.

Frontiers in bioscience (Scholar edition)| PubMed ID: 21622236

2011
2011
[Promoting remyelination by reducing an inhibitory microenvironment].

Rinsho shinkeigaku = Clinical neurology| PubMed ID: 21921479

2010
2015
The role of EMMPRIN in T cell biology and immunological diseases.

Journal of leukocyte biology| PubMed ID: 25977287

2015
2015
2015
2015
Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 26754802

2016
Monocytes increase human cardiac myofibroblast-mediated extracellular matrix remodeling through TGF-β1.

American journal of physiology. Heart and circulatory physiology| PubMed ID: 26801303

2016
2016
2016
2016
2016
2016
Regenerative Capacity of Macrophages for Remyelination.

Frontiers in cell and developmental biology| PubMed ID: 27243011

2016
Myeloid cells - targets of medication in multiple sclerosis.

Nature reviews. Neurology| PubMed ID: 27514287

2016
2017
2016
2016
2017
2017
2017
2017
Gestational bisphenol-A exposure lowers the threshold for autoimmunity in a model of multiple sclerosis.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 28439012

2017
Stop inflammation and you stop neurodegeneration in MS - YES.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 28463075

2017
2017
2018
2018
2017
Deficient Surveillance and Phagocytic Activity of Myeloid Cells Within Demyelinated Lesions in Aging Mice Visualized by Live Multiphoton Imaging.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 29363580

2018
2018
2018
Pro-inflammatory roles of chondroitin sulfate proteoglycans in disorders of the central nervous system.

Matrix biology : journal of the International Society for Matrix Biology| PubMed ID: 29702175

2018
2018
2018
2018
2018
2018
2018
2018
2018
2019
2019
2019
2019
2019
Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 31317818

2020
2019
2019
2020
2019
2020
2020
2020
2020
2020
2020
Control of brain tumor growth by reactivating myeloid cells with niacin.

Science translational medicine| PubMed ID: 32238578

2020
2020
2020
2020
2020
2021
2020
Exercise and the brain in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 33124511

2022
2020
Neuregulin-1 beta 1 is implicated in pathogenesis of multiple sclerosis.

Brain : a journal of neurology| PubMed ID: 33313801

2021
Intracerebral haemorrhage: from clinical settings to animal models.

Stroke and vascular neurology| PubMed ID: 33376200

2020
Combination of Hydroxychloroquine and Indapamide Attenuates Neurodegeneration in Models Relevant to Multiple Sclerosis.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics| PubMed ID: 33410109

2021
2021
2021
2021
2021
Harnessing the Benefits of Neuroinflammation: Generation of Macrophages/Microglia with Prominent Remyelinating Properties.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 33712513

2021
2021
2021
2021
2021
2023
An X-ray for myelin.

Trends in neurosciences| PubMed ID: 34148671

2021
2021
2021
2021
2021
2021
2021
MedXercise: a promising strategy to promote remyelination.

Current opinion in pharmacology| PubMed ID: 34688996

2021
2021
2022
2021
2022
2022
2021
2022
2022
Modes of Brain Cell Death Following Intracerebral Hemorrhage.

Frontiers in cellular neuroscience| PubMed ID: 35185473

2022
2022
Exercise training in multiple sclerosis.

The Lancet. Neurology| PubMed ID: 35305335

2022
2022
2022
Oxidized phospholipids as novel mediators of neurodegeneration.

Trends in neurosciences| PubMed ID: 35393134

2022
2022
2022
2022
Microglia in multiple sclerosis - pathogenesis and imaging.

Current opinion in neurology| PubMed ID: 35674072

2022
2022
2022
Iron Neurotoxicity and Protection by Deferoxamine in Intracerebral Hemorrhage.

Frontiers in molecular neuroscience| PubMed ID: 35782383

2022
Neuroprotection by Ozanimod Following Intracerebral Hemorrhage in Mice.

Frontiers in molecular neuroscience| PubMed ID: 35782389

2022
Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels.

Multiple sclerosis (Houndmills, Basingstoke, England)| PubMed ID: 35848622

2022
2022
2022
2022
Microglia-T cell conversations in brain cancer progression.

Trends in molecular medicine| PubMed ID: 36075812

2022
2022
2022
2023
2022
2023
Therapeutic strategies for intracerebral hemorrhage.

Frontiers in neurology| PubMed ID: 36408517

2022
2023
2022
2023
The Promise of Niacin in Neurology.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics| PubMed ID: 37084148

2023
2022
Single Cell Analysis of High-Parameter Histology Images Using Histoflow Cytometry.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 37133337

2023
2023
Elevated Galectin-3 Is Associated with Aging, Multiple Sclerosis, and Oxidized Phosphatidylcholine-Induced Neurodegeneration.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 37208177

2023
2023
Iron in multiple sclerosis - Neuropathology, immunology, and real-world considerations.

Multiple sclerosis and related disorders| PubMed ID: 37579645

2023
2023
2023
2023
Ion Channel Dysregulation Following Intracerebral Hemorrhage.

Neuroscience bulletin| PubMed ID: 37755675

2024
Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical| PubMed ID: 37829441

2023
2023
2023
Prominent elevation of extracellular matrix molecules in intracerebral hemorrhage.

Frontiers in molecular neuroscience| PubMed ID: 38025264

2023
2023
Towards improving the prognosis of stroke through targeting the circadian clock system.

International journal of biological sciences| PubMed ID: 38169640

2024
2024
2024
2024
Biology of neurofibrosis with focus on multiple sclerosis.

Frontiers in immunology| PubMed ID: 38596673

2024
2024
LXR agonism for CNS diseases: promises and challenges.

Journal of neuroinflammation| PubMed ID: 38627787

2024
2024
From progression to progress: The future of multiple sclerosis.

Journal of central nervous system disease| PubMed ID: 38711957

2024
2024